Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Monitoring and assessing vaccine safety: a European perspective.

Lopalco PL, Johansen K, Ciancio B, De Carvalho Gomes H, Kramarz P, Giesecke J.

Expert Rev Vaccines. 2010 Apr;9(4):371-80. doi: 10.1586/erv.10.20. Review.

PMID:
20370548
2.

Surveillance of adverse effects following vaccination and safety of immunization programs.

Waldman EA, Luhm KR, Monteiro SA, Freitas FR.

Rev Saude Publica. 2011 Feb;45(1):173-84. Review. English, Portuguese.

3.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
4.

Vaccinovigilance in Europe--need for timeliness, standardization and resources.

Lankinen KS, Pastila S, Kilpi T, Nohynek H, Mäkelä PH, Olin P.

Bull World Health Organ. 2004 Nov;82(11):828-35. Epub 2004 Dec 14.

6.

The Vaccine Safety Datalink: a model for monitoring immunization safety.

Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, Naleway A, Klein NP, Baxter R, Belongia E, Glanz J, Hambidge SJ, Jacobsen SJ, Jackson L, Nordin J, Weintraub E.

Pediatrics. 2011 May;127 Suppl 1:S45-53. doi: 10.1542/peds.2010-1722H. Epub 2011 Apr 18. Review.

PMID:
21502240
7.

Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.

LaRussa PS, Edwards KM, Dekker CL, Klein NP, Halsey NA, Marchant C, Baxter R, Engler RJ, Kissner J, Slade BA.

Pediatrics. 2011 May;127 Suppl 1:S65-73. doi: 10.1542/peds.2010-1722J. Epub 2011 Apr 18.

PMID:
21502239
8.

[Essential to monitor vaccine safety].

Heijbel H.

Lakartidningen. 2001 Sep 5;98(36):3777-8. Swedish.

PMID:
11586806
9.

Vaccination policies and programs: the federal government's role in making the system work.

Schwartz B, Orenstein WA.

Prim Care. 2001 Dec;28(4):697-711, v.

PMID:
11739026
10.

[Vaccines: adverse events surveillance].

Abarca V K.

Rev Chilena Infectol. 2007 Feb;24(1):53-6. Epub 2007 Mar 8. Spanish.

11.

Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.

Global Advisory Committee on Vaccine Safety (GACVS); WHO secretariat.

Expert Rev Vaccines. 2009 Jun;8(6):705-16. doi: 10.1586/erv.09.40. Review.

PMID:
19485752
12.

What is vaccine advocacy? Proposal for a definition and action.

Balinska MA.

Vaccine. 2004 Mar 29;22(11-12):1335-42. Review.

PMID:
15063555
13.

Weighing the risks and benefits of vaccination.

Glickman LT.

Adv Vet Med. 1999;41:701-13. Review.

PMID:
9890055
14.

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.

Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT.

Pediatr Infect Dis J. 2004 Apr;23(4):287-94. Review.

PMID:
15071280
15.

Safety monitoring in vaccine development and immunization.

Lee CJ, Lee LH, Lu CH, Huang YJ, Chu ML.

Acta Paediatr Taiwan. 2006 Jan-Feb;47(1):7-13. Review. Erratum in: Acta Paediatr Taiwan. 2006 Mar-Apr;47(2):100.

PMID:
17016963
16.

Methods of ensuring vaccine safety.

Ball R.

Expert Rev Vaccines. 2002 Aug;1(2):161-8. Review.

PMID:
12901555
17.

Postmarketing surveillance for dog and cat vaccines: new resources in changing times.

Moore GE, Frana TS, Guptill LF, Ward MP, Lewis HB, Glickman LT.

J Am Vet Med Assoc. 2005 Oct 1;227(7):1066-9. No abstract available.

PMID:
16220664
18.

The development of standardized case definitions and guidelines for adverse events following immunization.

Kohl KS, Gidudu J, Bonhoeffer J, Braun MM, Buettcher M, Chen RT, Drammeh B, Duclos P, Heijbel H, Heininger U, Hummelman E, Jefferson T, Keller-Stanislawski B, Loupi E, Marcy SM.

Vaccine. 2007 Aug 1;25(31):5671-4. Epub 2007 Mar 12. No abstract available.

PMID:
17400339
19.

[Surveillance of secondary effects of vaccination].

Duclos P.

Sante. 1994 May-Jun;4(3):215-20. French.

20.

The complicated task of monitoring vaccine safety.

Ellenberg SS, Chen RT.

Public Health Rep. 1997 Jan-Feb;112(1):10-20; discussion 21. Review.

Supplemental Content

Support Center